Caspe, Reynante C.
HRN: 25-41-65 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2024
CEFTRIAXONE 1G (VIAL)
07/03/2024
07/09/2024
IV
2g
Q24
Pneumonia
Waiting Final Action